Position history for GOLDMAN SACHS GROUP INC's holdings in RAPPORT THERAPEUTICS INC
GOLDMAN SACHS GROUP INC holds 2.9M shares of RAPP (RAPPORT THERAPEUTICS INC), worth $92.1M as of 2026-Q1. The position was decreased (-2.0% shares). RAPP represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.
Current Value
$92.1M
Current Shares
2.9M
Total Value Change
+$69.9M
Total Shares Change
+1.7M
Other major holders of RAPP: FMR LLC, Capital International Investors
Decreased |
| 2.9M |
-2.0% |
| $92.1M |
| 0.0% |
| $27.85 |
0 |
| 2025-Q4 | Increased | 3M | +23.9% | $91.1M | 0.0% | $30.64 | 36 |
| 2025-Q3 | Increased | 2.4M | +96.1% | $71.9M | 0.0% | $27.97 | 47 |
| 2025-Q2 | Decreased | 1.2M | -0.8% | $14M | 0.0% | $11.43 | 0 |
| 2025-Q1 | Decreased | 1.2M | -0.6% | $12.5M | 0.0% | $10.05 | 0 |
| 2024-Q4 | New | 1.3M | - | $22.2M | 0.0% | $18.49 | 39 |